BRIDGEWATER, N.J.--(BUSINESS WIRE)--April 20, 2006--Enzon Pharmaceuticals, Inc. (Nasdaq: ENZN - News) announced today that Jeffrey H. Buchalter, Enzon’s chairman and chief executive officer, will present at the UBS Warburg Global Life Sciences Conference, which is being held April 24 to 25 in New York City. Enzon’s presentation will take place at 8:30 a.m. EDT on Tuesday, April 25, 2006. The presentation will be webcast. Interested parties can access the webcast information by going to the events page that is under shareholder information on Enzon’s website at www.enzon.com.